Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
26.31
-0.12 (-0.45%)
Nov 20, 2026, 3:00 PM CST
| Market Cap | 11.34B -3.7% |
| Revenue (ttm) | 3.99B +5.7% |
| Net Income | 594.83M +4.1% |
| EPS | 1.39 +2.3% |
| Shares Out | 431.05M |
| PE Ratio | 18.96 |
| Forward PE | 17.03 |
| Dividend | 0.70 (2.66%) |
| Ex-Dividend Date | Aug 5, 2026 |
| Volume | 8,638,399 |
| Open | 26.40 |
| Previous Close | 26.43 |
| Day's Range | 26.01 - 26.52 |
| 52-Week Range | 21.22 - 30.18 |
| Beta | 0.15 |
| Analysts | Strong Buy |
| Price Target | 37.74 (+43.44%) |
| Earnings Date | Oct 30, 2026 |